Research Article
COVID-19: A Single-Center ICU Experience of the First Wave in the Philippines
Table 4
Variables and outcomes among COVID-19-confirmed patients.
| | ICU survivors (n = 9) | ICU nonsurvivors (n = 22) | value (two-tailed) |
| Demographics | | | | Age (years) | 59 (±12) | 67 (±12) | 0.151 | Gender (% of males) | 66.7% | 54.5% | 0.696 | SAPS-3 | 44 (±14.7) | 61.6 (±14.3) | 0.008 | Comorbidities | | | | Neurologic | | | 0.503 | Yes | 1 (11.1%) | 1 (4.5%) | | No | 8 (88.9%) | 21 (95.5%) | | Cardiovascular | | | 0.417 | Yes | 5 (55.6%) | 16 (72.7%) | | No | 4 (44.4%) | 6 (27.3%) | | Pulmonary | | | 0.642 | Yes | 1 (11.1%) | 5 (22.7%) | | No | 8 (88.9%) | 17 (80.6%) | | Renal | | | 1.000 | Yes | 0 | 2 (9.1%) | | No | 9 (100%) | 20 (90.9%) | | Endocrine | | | 0.433 | Yes | 3 (33.3%) | 12 (54.5%) | | No | 6 (66.7%) | 10 (45.5%) | | Autoimmune | | | 0.077 | Yes | 2 (22.2%) | 0 | | No | 7 (77.8%) | 22 (100%) | | Malignancy | | | 1.000 | Yes | 0 | 2 (9.1%) | | No | 9 (100%) | 20 (90.9%) | | Laboratories on ICU admission | | | | Hemoglobin (g/L) | 134 (±21) | 135 (±15) | 0.806 | WBC count (×103/µL) | 8.5 (±6.2) | 8.4 (±4) | 0.997 | Platelets (×109/L) | 259 (±109) | 204 (±50) | 0.179 | PF ratio | 201 (±152) | 148 (±73) | 0.344 | Lactate (mmol/L) | 1 (±2.5) | 2.2 (±2) | 0.021 | Treatment strategy | | | | Hydroxychloroquine | | | 0.642 | Yes | 8 (88.9%) | 17 (77.3%) | | No | 1 (11.1%) | 5 (22.7%) | | Tocilizumab | | | 0.456 | Yes | 6 (66.7%) | 11 (50%) | | No | 3 (33.3%) | 11 (50%) | | Lopinavir/ritonavir | | | 0.642 | Yes | 1 (11.1%) | 5 (22.7%) | 1 | No | 8 (88.9%) | 17 (77.3%) | | CRRT | | | 0.017 | Yes | 2 (22.2%) | 16 (72.7%) | | No | 7 (77.8%) | 6 (27.3%) | | NMBA | | | 0.642 | Yes | 1 (11.1%) | 5 (22.7%) | | No | 8 (88.9%) | 17 (77.3%) | | Prone positioning | | | 0.696 | Yes | 3 (33.3%) | 10 (45.5%) | | No | 6 (66.7%) | 12 (54.5%) | | IVIG | | | 1.000 | Yes | 1 (11.1%) | 2 (9.1%) | | No | 8 (88.9%) | 20 (90.9%) | | HA-330 | | | 1.000 | Yes | 2 (22.2%) | 6 (27.3%) | | No | 7 (77.8%) | 16 (72.7%) | | Intubation | | | 0.077 | Yes | 7 (77.8%) | 22 (100%) | | No | 2 (22.2%) | 0 | | Others | | | | Number of days intubated | 19 (±7) | 12 (±6) | 0.048 |
|
|